News from the healthcare data industry
Real-world data will likely play a bigger role in FDA drug reviews as the agency adopts lessons from Covid-19 to future regulatory decisions. The urgency of the pandemic has propelled U.S. health leaders to use data from sources such as patient medical records and mobile devices to help make decisions…
Newswise — Lawrenceville, NJ, USA—October 26, 2021—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry. The Real-World Evidence Transparency Initiative is a partnership between ISPOR, the International Society for Pharmacoepidemiology, the Duke-Margolis Center for Health Policy, and the National Pharmaceutical Council. While…
by Cerner CorporationPublished on October 26, 2021 Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered Cerner announces the launch of a new operating unit, Cerner EnvizaSM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The…
Tempus’ platform brings research to life with predictive algorithms that screen cancer patients for mutations in the DPYD gene Tempus, a leader in artificial intelligence and precision medicine, today announced its new DPYD algorithm as its most recent addition to its growing collection of predictive algorithm laboratory-developed tests. The test…
ATLANTA, GA, and NEW YORK, October 25, 2021 Grantees will get funding and data to research treatment and disparities among patients with advanced pancreatic and breast cancer The American Cancer Society (ACS) and Flatiron Health announced today that the 2021 Real-World Data Impact Awards will support research into health disparities…
NEW YORK, NY, October 21, 2021 — Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation. FDA and Aetion will use Aetion Evidence Platform® (AEP), validated software that…
Harrison will lead the company’s clinical commercial efforts, continuing to forge novel and essential partnerships across the healthcare community October 13, 2021 07:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced the appointment of Dymeka Harrison, MBA, as its Chief Commercial Officer. In this role, Harrison will…
LOUISVILLE, Colo. and SAN FRANCISCO, Oct. 13, 2021 — Trio Health (Trio), a leading provider of real-world data management and patient insights, and Datavant, the leader in helping healthcare organizations securely connect their data, today announced a strategic partnership that will enable Trio to connect its specialized multi-disease data assets…
Neal E. Storm DRSc, MS, MBA, RAC, Wen Chang PhD, Tzu-Chieh Lin PhD, Jeff L. Lange PhD, Brian Bradbury DSc, Cathy W. Critchlow PhD & Steven K. Galson MD, MPH Therapeutic Innovation & Regulatory Science (2021)Cite this article Abstract On June 23, 2020, Prolia® (denosumab) was approved by the National Medical Products Administration…
Sponsored by Syntropy | Oct 11, 2021 8:00am University of California, Irvine’s Health Affairs and Syntropy recently announced a new, five-year strategic partnership to transform how data is integrated and contextualized across the health research and health care continuum. The partnership supports the work to connect clinical-, research- and patient-reported data across the…